Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity

Molecular Endocrinology

Volumn 15, Issue 6, 2001, Pages 923-935

  Thompson, James ^a   Saatcioglu, Fahri ^c   Jänne, Olli A ^a   Palvimo, Jorma J ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HORMONE BINDING; HORMONE SENSITIVITY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSACTIVATION;

ANIMALIA;

EID: 0034982410     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.6.0647     Document Type: Article

References (58)

1. Androgen receptor defects: Historical, clinical, and molecular perspectives
2. Androgen resistance due to mutation of the androgen receptor
3. Steroid hormone receptors: Many actors in search of a plot
4. The nuclear receptor ligand-binding domain: Structure and function
5. Dominant negative regulation of trans-activation by the rat androgen receptor: Roles of the N-terminal domain and heterodimer formation
6. 2-terminal interaction with the ligand binding domain of the androgen receptor
7. The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells
8. Atomic structure of progesterone complexed with its receptor
9. Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implications for pathogenic gene mutations
10. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
11. 2-terminal domain
12. Nuclear receptor coregulators: Cellular and molecular biology
13. The coregulator exchange in transcriptional functions of nuclear receptors
14. Coactivator and corepressor complexes in nuclear receptor function
15. The SRC family of nuclear receptor coactivators
16. Structure and specificity of nuclear receptor-coactivator interactions
17. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins
18. A signature motif in transcriptional coactivators mediates binding to nuclear receptors
19. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
20. The androgen receptor gene mutations database
21. A canonical structure for the ligand-binding domain of nuclear receptors
22. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
23. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol
24. Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome
25. A single amino acid substitution (Gly743→Val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome
26. Complete androgen insensitivity syndrome associated with a de novo mutation of the androgen receptor gene detected by single strand conformation polymorphism
27. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene
28. Prevalence of androgen receptor gene mutations in latent prostatic carcinomas from Japanese men
29. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions
30. Agonists, but not antagonists, alter the conformation of the hormone-binding domain of androgen receptor
31. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization
32. A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: The mutated receptor fails to transactivate but binds to DNA in vitro
33. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
34. Mutual transcriptional interference between RelA and androgen receptor
35. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element
36. Transcription activating and repressing functions of the androgen receptor are differentially influenced by mutations in the deoxyribonucleic acid-binding domain
37. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
38. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains
39. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2)
40. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
41. An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors
42. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors α and β
43. Multifunctional analysis of the androgen receptor AF-2 core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors
44. Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene
45. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
46. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor
47. Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome
48. Inherited and de novo androgen receptor gene mutations: Investigation of single-case families
49. Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene
50. Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome
51. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
52. 2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity
53. Androgen-insensitivity syndrome as a possible coactivator disease
54. Transcriptional activation and nuclear targeting signals of the human androgen receptor
55. The p65 subunit is responsible for the strong transcription activating potential of NF-κB
56. Interaction of androgen receptors with androgen response element in intact cells. Roles of amino- and carboxyl-terminal regions and the ligand
57. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation
58. Nuclear androgen receptors in the mouse kidney: Validation of a new assay